10-93692719-T-C
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting
The NM_145246.5(FRA10AC1):c.307A>G(p.Lys103Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000197 in 1,579,700 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145246.5 missense
Scores
Clinical Significance
Conservation
Publications
- neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalitiesInheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152186Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000168 AC: 37AN: 220058 AF XY: 0.000192 show subpopulations
GnomAD4 exome AF: 0.000210 AC: 300AN: 1427396Hom.: 1 Cov.: 27 AF XY: 0.000241 AC XY: 171AN XY: 709962 show subpopulations
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152304Hom.: 0 Cov.: 31 AF XY: 0.0000806 AC XY: 6AN XY: 74476 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.307A>G (p.K103E) alteration is located in exon 6 (coding exon 5) of the FRA10AC1 gene. This alteration results from a A to G substitution at nucleotide position 307, causing the lysine (K) at amino acid position 103 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at